Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

類似資料

• Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab
  著者:: Kogawa, Takahiro, 等
  出版事項: (2020)
• Epidemiological Risk Factors Associated with Inflammatory Breast Cancer Subtypes
  著者:: Atkinson, Rachel L., 等
  出版事項: (2016)
• Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
  著者:: Li, Jing, 等
  出版事項: (2011)
• Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
  著者:: Kogawa, Takahiro, 等
  出版事項: (2015)
• Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system
  著者:: Fouad, Tamer M., 等
  出版事項: (2017)